{"organizations": [], "uuid": "bee33a82d9d0401849bf762b79a9ed73cc82ad54", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180108.html", "section_title": "Archive News &amp; Video for Monday, 08 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-amag-pharmaceuticals-sees-q4-2017/brief-amag-pharmaceuticals-sees-q4-2017-revenue-156-mln-to-163-mln-idUSASB0C036", "country": "US", "domain_rank": 408, "title": "BRIEF-AMAG Pharmaceuticals Sees Q4 2017 Revenue $156 Mln to $163 Mln", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 1.0, "site_type": "news", "published": "2018-01-08T21:18:00.000+02:00", "replies_count": 0, "uuid": "bee33a82d9d0401849bf762b79a9ed73cc82ad54"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-amag-pharmaceuticals-sees-q4-2017/brief-amag-pharmaceuticals-sees-q4-2017-revenue-156-mln-to-163-mln-idUSASB0C036", "ord_in_thread": 0, "title": "BRIEF-AMAG Pharmaceuticals Sees Q4 2017 Revenue $156 Mln to $163 Mln", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "amag pharmaceuticals inc", "sentiment": "negative"}, {"name": "amag", "sentiment": "negative"}, {"name": "ial", "sentiment": "none"}, {"name": "thomson reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 8 (Reuters) - AMAG Pharmaceuticals Inc:\n* AMAG PHARMACEUTICALS ANNOUNCES PRELIMINARY 2017 FINANCIAL RESULTS AND PROVIDES 2018 GUIDANCE\n* SEES Q4 2017 REVENUE $156 MILLION TO $163 MILLION * SEES FY 2017 REVENUE $613 MILLION TO $620 MILLION * SEES FY 2017 REVENUE UP 15 PERCENT * SEES Q4 2017 REVENUE UP ABOUT 5 PERCENT * - ‍FOR Q4 OF 2017, AMAG EXPECTS AN OPERATING LOSS OF BETWEEN $6 MILLION AND $16 MILLION​\n* - ‍EXPECTS 2017 TOTAL GAAP REVENUE TO BE BETWEEN $607 MILLION AND $614 MILLION​\n* SEES ‍ 2017 OPERATING LOSS OF BETWEEN $292 MILLION AND $302 MILLION (DUE PRIMARILY TO A Q3 NON-CASH ACCOUNTING CHARGE)​\n* SEES ‍2018 TOTAL GAAP REVENUE $500 MILLION - $560 MILLION​\n* SEES ‍2018 GAAP OPERATING LOSS $147 MILLION - $117 MILLION​\n* Q4 REVENUE VIEW $161.1 MILLION -- THOMSON REUTERS I/B/E/S\n* FY2017 REVENUE VIEW $616.0 MILLION -- THOMSON REUTERS I/B/E/S\n* FY2018 REVENUE VIEW $504.1 MILLION -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-08T21:18:00.000+02:00", "crawled": "2018-01-09T17:00:35.002+02:00", "highlightTitle": ""}